000 | 01015 a2200253 4500 | ||
---|---|---|---|
005 | 20250516013218.0 | ||
264 | 0 | _c20110503 | |
008 | 201105s 0 0 eng d | ||
022 | _a1464-3391 | ||
024 | 7 |
_a10.1016/j.bmc.2010.10.057 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhadka, Daulat Bikram | |
245 | 0 | 0 |
_a3-Arylisoquinolines as novel topoisomerase I inhibitors. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry _cJan 2011 |
||
300 |
_a724-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xchemistry |
650 | 0 | 4 |
_aIsoquinolines _xchemical synthesis |
650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xchemical synthesis |
700 | 1 | _aCho, Won-Jea | |
773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 19 _gno. 2 _gp. 724-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2010.10.057 _zAvailable from publisher's website |
999 |
_c20391304 _d20391304 |